Literatur
- 1
Cuillerier E, Lemann M, Bouhnik Y, Allez M, Rambaud J C, Modigliani R.
Azathioprine
for prevention of postoperative recurrence in Crohn’s disease:
a retrospective study.
Eur J Gastroenterol Hepatol.
2001;
13
1291-1296
- 2
Sandborn W J, Tremaine W J, Wolf D C, Targan S R, Sninsky C A, Sutherland L R, Hanauer S B,
McDonald J WD, Feagan B G, Fedorak R N, Isaacs K L, Pike M G, Mays D C, Lipsky J J,
Gordon S, Kleoudis C S, Murdock R H Jr. for the North American Azathioprine
Study Group .
Lack of Effect of Intravenous Administration on
Time to Respond to Azahioprine for Steroid-Treated Crohn’s
Disease.
Gastroenterology.
1999;
117
527-535
- 3
Colombel F J, Ferrari N, Debuysere H, Marteau P, Gendre J P, Bonaz B, Soule J C, Modigliani R.
Groupe D’Etudes
Therapeutique des Affections Inflammataires Digestives (GETAID),
Touze Y, Catala P, Libersa C and Broly F .
Cenotypic
Analysis of Thiopurine S-Methyltransferase in Patients With Crohn’s
Disease and Severe Myelosuppression During Azathioprine Therapy.
Gastroenterology.
2000;
118
1025-1035
- 4
Dubinsky M C, Lamothe S, Yang H Y. et al .
Pharmacogenomics and metabolite measurement
for 6-mercaptopurine therapy in inflammatory bowel disease.
Gastroenterology.
2000;
118
705-713
- 5
Lowry P W, Franklin C L, Weaver A L, Pike M G, Mays D C, Tremaine W J, Lipsky J J,
Sandborn W J.
Measurement of thiopurine methyltransferase
activity and azathioprine metabolites in patients with inflammatory bowel
disease.
Gut.
2001;
49
665-670
- 6
Present D H, Korelitz B I, Wisch N. et al .
Treatment of Crohn’s disease with
6-mercaptopurine. A long-term, randomized, double-blind study.
N
Engl J Med.
1980;
302
981-987
Autoren
PD Dr. med. Dr. phil. Gerhard Rogler,
Dr. med. Hans Herfarth
Klinik und Poliklinik für Innere Medizin I,
Universitätsklinik
93042 Regensburg
